Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
91,837,471
-
Total 13F shares
-
65,197,080
-
Share change
-
-3,770,886
-
Total reported value
-
$95,840,638
-
Price per share
-
$1.47
-
Number of holders
-
42
-
Value change
-
-$5,288,639
-
Number of buys
-
16
-
Number of sells
-
12
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q4 2025
As of 31 Dec 2025,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,197,080 shares.
The largest 10 holders included
MPM BIOIMPACT LLC, Blue Owl Capital Holdings LP, Nextech Invest, Ltd., Deep Track Capital, LP, Avidity Partners Management LP, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and MARSHALL WACE, LLP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.